medwireNews

The high side-effect burden of metastatic breast cancer treatments warrants the development of innovative dosing strategies to maintain quality of life, suggest the results of an advocate-led survey of patients.

The majority of patients with systemic lupus erythematosus and confirmed COVID-19 are able to produce a durable antibody response to the infection, despite the use of immunosuppressants, US research suggests.

Men who receive platinum-based chemotherapy or radiotherapy for testicular cancer have significantly higher long-term non-testicular cancer mortality rates than the general population, study findings indicate.

The small proportion of people who experience an eGFR fall of more than 30% on starting an SGLT2 inhibitor may be at increased risk for adverse outcomes, research suggests.

Adding the PD-L1 inhibitor durvalumab to neoadjuvant chemotherapy may improve survival outcomes in people with triple-negative breast cancer, show GeparNUEVO data presented at the 2021 ASCO Annual Meeting.

Tender joints in patients with rheumatoid arthritis may not be a suitable indicator of inflammation, study findings show.